THE EFFECTIVENESS OF MINIMALLY INVASIVE TECHNIQUES IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)

Benign Prostatic Hyperplasia (BPH) is a common urological condition affecting aging men, characterized by the noncancerous enlargement of the prostate gland. It often leads to lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, weak stream, and nocturia, significantly impacting quality of life. The prevalence of BPH increases with age, affecting approximately 50% of men aged 50 and older, and up to 90% of men by age 80. Traditionally, transurethral resection of the prostate (TURP) has been considered the gold standard surgical treatment for BPH. However, TURP is associated with potential complications including bleeding, urinary incontinence, and sexual dysfunction. Consequently, minimally invasive surgical therapies (MISTs) have gained popularity as alternatives that offer effective symptom relief with fewer side effects. This study aims to evaluate the efficacy and safety of various minimally invasive techniques such as laser enucleation, UroLift, and Rezūm therapy in the management of BPH and their impact on patient outcomes.